References
- International Diabetes FederationDiabetes Atlas7th edBrussels, BelgiumInternational Diabetes Federation2015 Available from: http://www.diabetesatlas.org/Accessed August 14, 2016
- GuariguataLWhitingDRHambletonIBeagleyJLinnenkampUShawJEGlobal estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Res Clin Pract2014103213714924630390
- China Guideline for Type 2 Diabetes (2013 version)Chin J Diabetes201408242
- Centers for DiseaseControl and Prevention2014 National Diabetes Statistics Report. Available from: http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.htmlAccessed August 31, 2015
- American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201336Suppl 1S67S7423264425
- KumarVAbbasAKFaustoNRobbinsSLCotranRSRobbins and Cotran Pathologic Basis of DiseasePhiladelphia, PAElsevier Saunders2005
- HolmanRRPaulSKBethelMAMatthewsDRNeilHA10-Year follow-up of intensive glucose control in type 2 diabetesN Engl J Med20083591577158918784090
- StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBr Med J200032140541210938048
- American Diabetes AssociationStandards of medical care in diabetesDiabetes Care201235S11S6322187469
- NICE Type 2 diabetesNICE Type 2 diabetesNational Clinical Guideline for Management in Primary and Secondary Care (update)London, UKNational Institute for Health and Clinical Excellence2008
- NathanDMBuseJBDavidsonMBMedical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care20093219320318945920
- Chinese Diabetes SocietyChina Guideline for Type 2 Diabetes (2010 version) Available from: http://www.diab.net.cn/uploadfile/ueditor/file/20160811/6360650768334000005174021.pdfAccessed November 23, 2016
- PanCYangWJiaWWengJTianHManagement of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveysCurr Med Res Opin2009251394519210137
- BaserOBouchardJDeLuzioTHenkHAagrenMAssessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringeAdv Ther20102729410420352392
- CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health200811444718237359
- EgedeLEGebregziabherMHuntKJRegional, geographic, and ethnic differences in medication adherence among adults with type 2 diabetesAnn Pharmacother201145216917821304026
- BonafedeMMKalsekarAPawaskarMA retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixturesPatient Prefer Adherence2010414715620622915
- BuysmanEConnerCAagrenMBouchardJLiuFAdherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetesCurr Med Res Opin2011271709171721740289
- Ascher-SvanumHLageMJPerez-NievesMEarly discontinuation and restart of insulin in the treatment of type 2 diabetes mellitusDiabetes Ther2014522524224782063
- CramerJAA systematic review of adherence with medications for diabetesDiabetes Care2004271218122415111553
- DaviesMJGagliardinoJJGrayLJKhuntiKMohanVHughesRReal-world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic reviewDiabet Med201330551252423323988
- WeiWPanCXieLBaserOReal-world insulin treatment persistence among patients with type 2 diabetesEndocr Pract2014201526124013990
- CaoMMDongNWInterpretation of Chinese Society of Endocrinology (2010) consensus statement on HbHbA1c control target in adults with type 2 diabetes in China (in Chinese)Chinese J Pract Internal Med2011312113115
- LinXHuangXChenLThe insulin adherence and nursing intervention among T2D patients and the Chinese (in Chinese)Prim Health Care2011259293
- WangAZhangZThe adherence and intervention among T2D patients initiated with intensifying insulin therapy (in Chinese)P Clin Med200716217219
- QinHLuHThe insulin adherence among T2D patients after discharge (in Chinese)Internal Med China20127669670
- Tianjin Daily592012 Available from: http://www.gov.cn/gzdt/2012-05/09/content_2132977.htmAccessed August 31, 2015
- QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care2005431130113916224307
- WangLWeiWMiaoRXieLBaserOReal-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database studyBMJ Open20133419
- Van WijkBLKlungelOHHeerdinkERde BoerAThe association between compliance with antihypertensive drugs and modification of antihypertensive drug regimenJ Hypertens2004221831183715311113
- LiJMcCombsJSStimmelGLCost of treating bipolar disorder in the California Medicaid (Medi-Cal) programJ Affect Disord20027113113912167509
- PawaskarMBonafedeMJohnsonBFowlerRLenhartGHoogwerfBMedication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database studyBMC Endocr Disord2013132023799930
- Bank of ChinaForeign Exchange Rate Available from: http://srh.bankofchina.com/search/whpj/search.jspAccessed August 31, 2015
- OgberaAOKukuSFInsulin use, prescription patterns, regimens and costs.-a narrative from a developing countryDiabetol Metab Syndr2012415023199230
- AzizKMManagement of type-1 and type-2 diabetes by insulin injections in diabetology clinics – a scientific research reviewRecent Pat Endocr Metab Immune Drug Discov2012614817022559241
- ChrvalaCASherrDLipmanRDDiabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic controlPatient Educ Couns20169992694326658704
- PeyrotMRubinRRFactors associated with persistence and resumption of insulin pen use for patients with type 2 diabetesDiabetes Technol Ther201113434821175270
- CookeCELeeHYTongYPHainesSTPersistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organizationCurr Med Res Opin20102623123819921965
- HertzRPUngerANLustikMBAdherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insuranceClin Ther2005271064107316154485
- BonafedeMMKalsekarAPawaskarMInsulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysisBMC Endocr Disord201111321226935
- BaragSHInsulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherenceJ Am Osteopath Assoc20111117 Suppl 5S13S19
- BaserOTangiralaKWeiWXieLReal-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugsClinicoecon Outcomes Res201335497505
- YangJLiJPremixed or basal insulin: the insulin initiation consideration in Chinese patients with type2 diabetes mellitusChin J Endocrinol Metab20132915
- LeeWCBaluSCobdenDMedication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims dataClin Ther2006281712172517157128
- FarsaeiSRadfarMHeydariZAbbasiFQorbaniMInsulin adherence in patients with diabetes: risk factors for injection omissionPrim Care Diabetes2014833834524721139